A comprehensive view of biopharmaceuticals / biologics. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.
Recent Articles
sample of recent headlines, press releases and get more..
Merck KGaA regains worldwide rights to cancer immunotherapy Bavencio, ending collaboration with Pfizer; 15% royalty on net sales to be paid to Pfizer.
Published:
March 28, 2023
by SeeNews Pharmaceuticals
|
Regeneron and Sonoma Biotherapeutics partner to discover, develop, commercialize novel regulatory T cell therapies for autoimmune diseases including ulcerative colitis, Crohn’s disease; Sonoma receives US$75.0M upfront
Published:
March 28, 2023
by Regeneron Pharmaceuticals Inc.
|
BioNTech Q4 profit down at €2.28B from €3.17B a year ago on weak revenues of €4.28B; sees FY23 COVID-19 vaccine revenues of €5.0B
Published:
March 27, 2023
by CE Noticias Financieras (Latin America)
|
BioNTech Announces Fourth Quarter and Full Year 2022 Financial Results and Corporate Update
Published:
March 27, 2023
by BioNTech SE
|
US biopharma firm JanOne names John N Bonfiglio, PhD, as interim president of its JanOne Biotech subsidiary; Dr. Bonfiglio previously served as CEO at Peregrine Pharmaceuticals
Published:
March 24, 2023
by PR Newswire
|
Ask us about our Health Care Sector market view
Trending Chart
Interactive chart with headline count